Corcept Therapeutics Financial Overview
Corcept Therapeutics's market cap is currently $8.81B. The company's EPS TTM is $0.16; its P/E ratio is 97.25; Corcept Therapeutics is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $0.38. See an overview of income statement, balance sheet, and cash flow financials.
